<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-vaccines-08-00531">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Monteagudo</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Lacasta</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>López</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bosch</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Collado</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Pina-Pedrero</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Correa-Fiz</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Accensi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Navas</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Vidal</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>BA71ΔCD2: A New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities</article-title>
  <source>J. Virol.</source>
  <year>2017</year>
  <volume>91</volume>
  <pub-id pub-id-type="doi">10.1128/JVI.01058-17</pub-id>
  <?supplied-pmid 28814514?>
  <pub-id pub-id-type="pmid">28814514</pub-id>
 </element-citation>
</ref>
